BETA
Early release — we are building new features fast, you may encounter issues. Help us improve:
contact us
to report bugs or share feedback.
✕
Loading...
Analytics
Equity Analytics
On the record this week: what the Street published, what insiders filed, and what reports next.
←
Back to Equity Analytics
Equity Analytics
/
SOLV
SOLV
Solventum Corporation
Healthcare - US
Solventum Corporation (NYSE: SOLV) develops, manufactures and commercializes healthcare solutions at the intersection of health, material and data science, including advanced wound care such as negative pressure wound therapy and surgical i…
Show more
HQ: Eagan, MN, United States of America
www.solventum.com
USD
87.45
-0.23%
vs prev. close
Overview
Fundamentals
Ownership & Activity
Analyst Consensus
Seasonality & Patterns
News
Research
Market snapshot
Price
USD
87.45
Daily move
-0.23%
P/E
10.7
EPS TTM
8.16
Dividend yield
—
Beta
0.69
Market cap
14.9B
Price history
SOLV price
USD
Line
Candle
Volume
Log scale
1m
3m
6m
1y
3y
5y
10y
max
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Valuation & performance
Risk
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Solventum
SOLV
Medical Instruments & Supplies
14.9
10.7
—
-4.6%
+2.5%
+10.9%
+31.0%
+18.5%
+10.4%
🔒
Subscribe to Equity Analytics to compare SOLV with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.
View plans
Ask Ashenden
One question, one concise answer grounded in Ashenden research.
Ask
Built on Ashenden research and our own data. Answers are AI-generated: they can be wrong or incomplete — check anything you would act on.
Is SOLV cheap or expensive against its peers, and what justifies the gap?
What does the price already assume about SOLV?
What would have to go wrong for SOLV from here?
Why SOLV now, and not a year ago?